Standout Papers
- Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer (2012)
- Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial (2016)
- Palbociclib in Hormone-Receptor–Positive Advanced Breast Cancer (2015)
- Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer (2018)
- Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trial (2017)
Immediate Impact
4 by Nobel laureates 6 from Science/Nature 76 standout
Citing Papers
Overall Survival With Palbociclib Plus Letrozole in Advanced Breast Cancer
2024 Standout
Analysis of Breast Cancer Mortality in the US—1975 to 2019
2024 Standout
Works of Sunil Verma being referenced
Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer
2018 Standout
Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trial
2017 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Sunil Verma | 7624 | 4936 | 2428 | 159 | 10.3k | |
| Jean-Marc Ferrero | 6284 | 3884 | 2928 | 207 | 9.3k | |
| Kimberly Blackwell | 5876 | 2367 | 1844 | 139 | 8.9k | |
| Andrew D. Seidman | 7951 | 2423 | 2143 | 206 | 10.8k | |
| Denise A. Yardley | 9529 | 4373 | 3183 | 277 | 12.4k | |
| Sara A. Hurvitz | 7870 | 4084 | 2491 | 367 | 10.6k | |
| Maura N. Dickler | 6313 | 3212 | 2741 | 164 | 10.3k | |
| Mark Rosenthal | 2721 | 5812 | 1827 | 203 | 10.0k | |
| Tadeusz Pieńkowski | 9343 | 2438 | 3720 | 129 | 11.6k | |
| Carey K. Anders | 5242 | 2683 | 2498 | 204 | 8.3k | |
| Francesco Cognetti | 4930 | 2271 | 1656 | 221 | 8.3k |
All Works
Login with ORCID to disown or claim papers
Loading papers...